EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of anaemia with intravenous iron in patients with end-stage renal failure being on hemodialysis



Treatment of anaemia with intravenous iron in patients with end-stage renal failure being on hemodialysis



Nephrology Dialysis Transplantation 14(9): A170, Sept




(PDF 0-2 workdays service: $29.90)

Accession: 035980937

Download citation: RISBibTeXText



Related references

Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrology, Dialysis, Transplantation 21(1): 120-124, 2005

Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron. Nephrology, Dialysis, Transplantation 20(7): 1512-3; Author Reply 1513-4, 2005

The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease. Nephrology Nursing Journal 27(1): 41-42, 2000

Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis. American Journal of Therapeutics 21(4): 250-253, 2015

Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. British Journal of Haematology 79(4): 634-639, 1991

Intermittent intravenous 1 alpha hydroxycholecalciferol reduces intact plasma parathyroid hormone in patients with end stage renal failure on long term hemodialysis. Kidney International 35(1): 390, 1989

Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure. Nephrology, Dialysis, Transplantation 10(12): 2374-2375, 1995

Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin. Nephrology, Dialysis, Transplantation 20 Suppl 3: Iii25-Iii32, 2005

Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis. Polskie Archiwum Medycyny Wewnetrznej 110(1): 703-710, 2003

Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment. Wiener Medizinische Wochenschrift 130(4): 171-173, 1980

Our experience in the chronic hemodialysis treatment of diabetic patients with end stage renal failure. Orvosi Hetilap 136(50): 2715-2720, 1995

Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?. Nephrology, Dialysis, Transplantation 20 Suppl 7: Vii16-Vii23, 2005

Complementary use of peritoneal and hemodialysis: therapeutic synergies in the treatment of end-stage renal failure patients. Kidney International. Supplement: S63-S67, 2008

Comparative study of intravenous iron versus intravenous ascorbic Acid for treatment of functional iron deficiency in patients under hemodialysis: a randomized clinical trial. Nephro-Urology Monthly 5(4): 913-917, 2013